Friday, November 19, 2021 7:53:14 PM
spuds its been a rough road for sure but now is the time to be buying not selling,adult test sales are getting better,pedi approval will be by the middle of next yr rt,again thats for an unmet need and sales will be big because there is no way to test a kid for ghd,what about the trials is usa for macrilen for cancer cachexia and tbi,even if 1 use gets approved it will be big news,all the licensing deals many of them also being for unmet needs,do what u will but i was once down 90% in aezs but ended up making some good money because i loaded the boat at 30 cents and it went over a buck and then over 3 bucks before retracing lately,the same will happen to u if u just hold,the burn rate is so low and aezs has 60 mill in the bank so no raise needed and many things coming as u know,just wait it out,pedi approval alone will make this bounce and when some of he other catalysts come to fruition this will climb,is it 100%,no but im telling u i was down 90% once and ended up making some good money because i held and averaged way down,im down rt now 10k but will hold,again these catalysts even if they are a way off wll pay off and at worst u have pedi approval which is for an unmet need,hold for another 6 months at least and remember novo will push pedi test bigtime as it will be the only way to test kids for ghd and it will have sales in eu 2,God bless and good luck whatever u do but u would be selling near the bottom,it cant go down much more imo
Recent CSCIF News
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/20/2026 08:46:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2026 08:38:12 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/12/2026 09:21:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 09:07:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 09:05:51 PM
- COSCIENS Biopharma Inc. Reports Q1 2026 Results • GlobeNewswire Inc. • 05/12/2026 09:05:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/08/2026 08:45:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2026 08:45:07 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 04/20/2026 12:01:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/20/2026 12:00:12 PM
- COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:55:15 PM
- COSCIENS Comments on Unusual Market Activity • GlobeNewswire Inc. • 04/07/2026 09:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/07/2026 09:07:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 09:05:27 PM
- COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/25/2026 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/19/2026 04:15:19 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:57 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:39 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:14 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/13/2026 09:29:54 PM
